OC Fair announces new CEO as July opening nears
About a month before the return of the Orange County Fair, the event's board of directors announced Monday it has found a new chief executive officer.
James Canfield will succeed Michele Richards, who announced in January she would retire in May to move to Georgia and help care for family members.
His first day on the job will be July 1. The annual fair returns July 18 and runs through Aug. 17.
Canfield most recently served as senior director and general manager of the Birmingham Jefferson Convention Complex in Alabama.
The position at the OC Fair & Event Center in Costa Mesa marks a return to California, where he previously held management roles at convention centers in Palm Springs, Pasadena and Long Beach.
'I am very excited to return to California and to have the great opportunity to lead OC Fair & Event Center into a new era that builds on its rich legacy while advancing innovation and community-focused programming,' Canfield said in a news release issued Monday by the OC Fair & Event Center Board of Directors. 'I am very much looking forward to opening day of this year's OC Fair.'
OC Board Chairman Nick Kovacevich praised Canfield's 'extensive experience in managing premier convention and entertainment venues,' calling him 'exceptionally well-suited to lead our organization into its nextchapter.''
Kovacevich added that Canfield's 'innovative approach and dedication to operational excellence will ensure that the OC Fair and our year-round events continue to be cherished community traditions delivering joy, education and memorable experiences to all who visit. We look forward to the fresh perspective and dynamic leadership he will bring to our team.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
SAIF Partners Files Definitive Proxy Materials in Connection with Sinovac Biotech 2025 Special Meeting of Shareholders; Nominates Ten Highly Qualified Director Candidates to the Board
Sends Open Letter to Sinovac Shareholders Calling for a New Board to End Years of Chaos at Sinovac SAIF Nominees Will Work to Resolve Costly Legal Battles, Take Action to Resume Stock Trading after Six-Year Halt, and Facilitate Distribution of Cash That Rightfully Belongs to Shareholders Urges Sinovac Shareholders to VOTE the GOLD Proxy Card FOR the Election of SAIF's Director Nominees BEIJING, June 16, 2025--(BUSINESS WIRE)--SAIF Partners IV L.P., ("SAIF Partners"), the largest single investor in Sinovac Biotech Ltd. ("Sinovac" or the "Company"), beneficially owning approximately 15% of the outstanding common shares, today announced that it has filed a definitive proxy statement for the election of ten director nominees to Sinovac's Board of Directors (the "Board") in connection with the special meeting of the shareholders of the Company to be held on Tuesday, July 8, 2025 at 8 p.m. Atlantic Standard Time (Wednesday, July 9, 2025 at 8:00 a.m. China Standard Time), and at any adjourned, postponed, continued, or rescheduled meeting thereof (the "Special Meeting"). Additionally, SAIF Partners issued an open letter to its fellow Sinovac shareholders outlining its belief that new highly qualified directors are required to effectively resolve the significant challenges Sinovac currently faces and deliver value for all shareholders. In the letter, SAIF details how the Board has not effectively guided Sinovac after the significant chaos of the past several years, including, among other issues, strategic missteps, costly and distracting legal battles, a stock that does not trade, and a large amount of cash that the Company is inexplicably retaining rather than distributing it to shareholders as they should. If elected, SAIF Partners' nominees will work with management to develop a plan to address these issues and bring disciplined corporate governance, proper capital allocation, strategic foresight and operational excellence to Sinovac. SAIF Partners has outlined the most critical priorities for Sinovac that their nominees would seek to address if elected, including declaring additional dividends, resuming trading of common shares and resolving shareholder disputes. The full text of the letter is below. June 16, 2025 Dear Fellow Sinovac Shareholder: As the largest single investor and a long-term shareholder in Sinovac Biotech Ltd. ("Sinovac" or the "Company"), beneficially owning approximately 15% of the outstanding common shares, SAIF Partners ("SAIF") believes deeply in the Company's products and tremendous potential to create long-lasting value for all shareholders. However, Sinovac's Board of Directors (the "Board") has not effectively guided Sinovac after the significant chaos of the past several years, including, among other issues, strategic missteps, costly and distracting legal battles, a stock that does not trade, and a large amount of cash that the Company is inexplicably retaining rather than distributing it to shareholders as they should. The Board has done nothing to address these issues and only began to acknowledge them after we forced Sinovac to hold a special meeting to replace directors. Simply put, the status quo is not working. Sinovac desperately needs new and experienced directors dedicated to putting Sinovac back on the right track through disciplined corporate governance, proper capital allocation, strategic foresight and operational excellence – and acting in the best interests of ALL Sinovac shareholders. As such, SAIF is nominating highly qualified candidates for election to the Board at the special meeting of shareholders to be held July 8, 2025. We have taken this important action to address key issues at Sinovac that, if elected, will be top priorities for our nominees, including: 1. Declaration of Additional Dividend. We believe there are billions of US dollars of available cash in Sinovac's accounts and that Sinovac can and should pay more dividends to shareholders in addition to the $55.00 per share special dividend declared by the Board on April 1, 2025, which would not have been announced without our engagement. Further, dividends have been paid from Sinovac subsidiaries, but not to shareholders. Our nominees will determine, in close collaboration with management, on the appropriate allocation of retained earnings and facilitate the distribution of long-overdue returns to all shareholders. 2. Resumption of Trading of Common Shares of the Company. Sinovac shares have not traded for more than six years, denying shareholders the liquidity they deserve. Our nominees will take immediate steps to address compliance issues and work expeditiously towards the resumption of trading of the Company's shares. 3. Resolution of Shareholder Disputes and Unlocking the Company's Full Potential. Sinovac has been entrapped in endless disputes and prolonged lawsuits since 2018. We are concerned that the series of legal disputes started recently will cause more crisis and destruction to the interests of the Company and its shareholders. Our nominees will engage with these shareholders to amicably resolve ongoing disputes, eliminate divisions, and foster alignment among shareholders in order to focus on Sinovac's core mission, and drive growth and value. 4. Strategic Realignment for Shareholder Value Creation. Sinovac's Board does not currently have a strategic plan in place that reflects the realities of the current market environment and positions the Company to capitalize on emerging opportunities in the biopharmaceutical sector. Our nominees will work closely with Sinovac management to develop a business strategy with clear operational objectives to drive long-term value for all shareholders. A NEW BOARD IS DESPERATELY NEEDED TO RESTORE CREDIBILITY AND ENSURE SHAREHOLDER VALUE IS NOT FURTHER ERODED Sinovac shareholders deserve a Board that is unbiased in its decision making and dedicated to acting on behalf of all shareholders rather than for a select few. Presently, all but one member of the Board are representatives of 1Globe and OrbiMed, whose influence far exceeds their respective 9.5% and 3.8% ownership stakes in Sinovac. We believe our nominees – who represent a broad base of major Sinovac shareholders including Weidong Yin (the CEO and founder of the Company), SAIF Partners, Vivo Capital, CDH Investment, Advantech Capital, and 1Globe – will comprise a well-balanced and diversified Board with extensive industry knowledge, experience and insights necessary to end costly and distracting internal strife, and execute a clear strategic plan that maximizes sustainable, long-term value for ALL shareholders. Certain of our nominees have key management experience at Sinovac and will work closely with the Company management team to drive long-term value for all shareholders. We urge you to join us and vote the GOLD proxy card in support of our highly qualified nominees who will make the changes necessary to help Sinovac realize its tremendous potential and build the value of Sinovac for all shareholders. Please vote on the GOLD proxy card TODAY! Sincerely, SAIF Partners YOUR VOTE IS IMPORTANT, NO MATTER HOW MANY OR HOW FEW SHARES YOU OWN! Please vote today by telephone or via the Internet by following the easy instructions on the GOLD proxy card. If you have any questions or require assistance in authorizing a proxy or voting your common shares, please contact: Sodali & Co 430 Park Avenue, 14th Floor New York, NY 10022 Call Toll-Free in North America: (800) 662-5200 Outside of North America Call Collect: (203) 658-9400 Email: SAIF@ Please do not return any proxy card you may receive from the Company or otherwise authorize a Company's proxy to vote your common shares at the special meeting, not even as a protest vote. If you have already sent a proxy card to the Company or otherwise authorized a Company's proxy to vote your common shares at the special meeting, it is not too late to change your vote by using the enclosed GOLD proxy card. Only your latest dated proxy will be counted. About SAIF PartnersSAIF Partners is a leading Asian private equity firm with cumulative assets under management of over $4 billion. SAIF Partners is an active lead investor working closely with its portfolio companies to develop their business both organically and through acquisitions, seeking synergistic cooperation among them, as well as enhancing shareholder value via promotion of good corporate governance and best management practices. Additional Information and Where to Find It This communication may be deemed to be solicitation material in respect of SAIF Partners' nomination of ten director nominees to Sinovac's Board. In connection with such solicitation, SAIF Partners mailed the definitive proxy statement and proxy card to shareholders of Sinovac with respect to the Special Meeting to be held in connection with the election of directors to Sinovac's Board. The definitive proxy statement mailed by SAIF Partners is also filed as Exhibit 1 to its Schedule 13D/A filed on or about June 16, 2025. SHAREHOLDERS ARE URGED TO READ THE PROXY STATEMENT (INCLUDING ANY AMENDMENTS OR SUPPLEMENTS THERETO) AND ANY OTHER RELEVANT DOCUMENTS THAT THE COMPANY WILL MAIL AND FILE WITH THE SEC IN CONNECTION WITH THE SINOVAC SPECIAL MEETING, INCLUDING ANY DOCUMENT INCORPORATED BY REFERENCE THEREIN, CAREFULLY IF AND WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT THE DIRECTOR NOMINEES AND THE SPECIAL MEETING AND RELATED MATTERS. Sinovac's shareholders may obtain, free of charge, the definitive version of the proxy statement, any amendments or supplements thereto, and any other relevant documents mailed by SAIF Partners in connection with the Special Meeting at View source version on Contacts Media Contacts Jonathan Gasthalter/Mark Semer/Grace CartwrightGasthalter & Co.+1 (212) 257 4170SAIF@ Investor Contacts Paul Schulman/Bill Dooley/Jon EylSodali & Co.+ 1 (203) 658-9400SAIF@
Yahoo
4 hours ago
- Yahoo
Brookfield Renewable Corporation Announces Results of Annual Meeting of Shareholders
BROOKFIELD, NEWS, June 16, 2025 (GLOBE NEWSWIRE) -- Brookfield Renewable Corporation (the 'Corporation') (TSX, NYSE: BEPC) today announced that all eight nominees proposed for election to the board of directors of the Corporation by holders of class A exchangeable subordinate voting shares ('Exchangeable Shares') and holders of class B multiple voting shares ('Class B Shares') were elected at the Corporation's annual meeting of shareholders held on June 16, 2025 in a virtual meeting format and that Ernst & Young LLP have been re-appointed as the corporation's external auditor. Detailed results of the vote for the election of directors are set out below. In accordance with the Corporation's articles, each Exchangeable Share was entitled to one vote per share, representing a 25% voting interest in the Corporation in the aggregate, and the Class B Shares were entitled to a total of 434,657,409 votes in the aggregate, representing a 75% voting interest in the Corporation. The following is a summary of the votes cast by holders of Exchangeable Shares and Class B Shares, voting together as a single class, in regard to the election of the eight directors: Director Nominee Votes For % Votes Withheld % Jeffrey Blidner 482,820,764 91.31 % 45,962,036 8.69 % Sarah Deasley 527,800,142 99.81 % 982,659 0.19 % Nancy Dorn 520,643,761 98.46 % 8,139,040 1.54 % Eleazar de Carvalho Filho 527,545,478 99.77 % 1,237,321 0.23 % Randy MacEwen 527,645,430 99.78 % 1,137,371 0.22 % Lou Maroun 515,462,819 97.48 % 13,319,981 2.52 % Stephen Westwell 520,624,339 98.46 % 8,158,461 1.54 % Patricia Zuccotti 527,675,815 99.79 % 1,106,986 0.21 % A summary of all votes cast by holders of the Exchangeable Shares and Class B Shares represented at the Corporation's annual meeting of shareholders is available on SEDAR+ at Brookfield Renewable Brookfield Renewable operates one of the world's largest publicly traded platforms for renewable power and sustainable solutions. Our renewable power portfolio consists of hydroelectric, wind, utility-scale solar and storage facilities and our sustainable solutions assets include our investment in a leading global nuclear services business and a portfolio of investments in carbon capture and storage capacity, agricultural renewable natural gas, materials recycling and eFuels manufacturing capacity, among others. Investors can access the portfolio either through Brookfield Renewable Partners L.P. (NYSE: BEP; TSX: a Bermuda-based limited partnership, or Brookfield Renewable Corporation (NYSE, TSX: BEPC), a Canadian corporation. Brookfield Renewable is the flagship listed renewable power and transition company of Brookfield Asset Management, a leading global alternative asset manager headquartered in New York, with over $1 trillion of assets under management. Contact information: Media: Investors: Simon Maine Alex Jackson +44 7398 909 278 +1 (416) 649-8172 Sign in to access your portfolio
Yahoo
5 hours ago
- Yahoo
Duff & Phelps Utility and Infrastructure Fund Inc. Announces Renewal of Share Repurchase Program and Monthly Distributions
CHICAGO, June 16, 2025--(BUSINESS WIRE)--The Board of Directors of Duff & Phelps Utility and Infrastructure Fund Inc. (NYSE: DPG), a closed-end fund advised by Duff & Phelps Investment Management Co. (the "Adviser"), announced today the renewal of its open market share repurchase program. Under the Fund's current repurchase program the Fund is authorized to purchase, on a discretionary basis through June 30, 2025, up to 5% of its outstanding common shares on the open market at a discount to net asset value ("NAV"). Pursuant to the renewed share repurchase program, commencing July 1, 2025, the Fund may repurchase up to 5% of its outstanding common shares (based on common shares outstanding on June 30, 2025) on the open market at a discount to NAV through June 30, 2026. The repurchase program seeks to enhance shareholder value by purchasing shares of the Fund in the open market at a discount to NAV, which could result in incremental accretion to the Fund's NAV. Under the program, the amount and timing of repurchases will be at the discretion of the Adviser and subject to market conditions and investment considerations. There is no assurance that the Fund will purchase shares at any particular discount levels or in any particular amounts. Any repurchases made under the program will be subject to New York Stock Exchange requirements and volume, timing, and other limitations under federal securities laws. The Fund's share repurchase activity will be disclosed in the annual and semi-annual reports to shareholders. The Board has authorized the payment of dividends on its common stock as follows: Per Share Amount Ex-Date Record Date Payable Date $0.07 July 31, 2025 July 31, 2025 August 11, 2025 $0.07 August 29, 2025 August 29, 2025 September 10, 2025 $0.07 September 30, 2025 September 30, 2025 October 10, 2025 The Fund adopted a managed distribution plan (the "Plan") in 2015. Under the Plan, the Fund will distribute all available investment income to its shareholders, consistent with the Fund's investment objective. If and when sufficient investment income is not available on a monthly basis, the Fund will distribute realized capital gains and/or return of capital to its shareholders in order to maintain the monthly $0.07 per share distribution level. The following table sets forth the estimated amounts of the Fund's May 2025 distribution to shareholders of record at the close of business on May 30, 2025 (ex-date May 30, 2025), payable June 10, 2025, together with the cumulative distributions paid from the first day of the fiscal year to this month end from the following sources. All amounts are expressed per share of common stock based on U.S. generally accepted accounting principles which may differ from federal income tax regulations. Distribution Estimates May 2025 (MTD) Year-to-Date (YTD)(1) (Sources) Per Share Amount Percentage of Current Distribution Per Share Amount Percentage of Current Distribution Net Investment Income $ 0.070 100.0% $ 0.107 21.8% Net Realized Short-Term Capital Gains 0.000 0.0% 0.146 29.7% Net Realized Long-Term Capital Gains 0.000 0.0% 0.237 48.5% Return of Capital (or other Capital Source) 0.000 0.0% 0.000 0.0% Total Distribution $ 0.070 100.0% $ 0.490 100.0% (1) Fiscal year started November 1, 2024. As of May 30, 2025 Average annual total return on NAV for the 5 years 12.24% Annualized current distribution rate as a percentage of NAV 6.18% Cumulative total return on NAV for the fiscal year 10.26% Cumulative fiscal year distributions as a percentage of NAV 3.61% The Fund will issue a separate 19(a) notice at the time of each distribution using the most current financial information available. You should not draw any conclusions about the Fund's investment performance from the amount of these distributions or from the terms of the Plan. The amounts and sources of distributions reported in this notice are only estimates and are not being provided for tax reporting purposes. The actual amounts and sources of the amounts for tax reporting purposes will depend upon the Fund's investment experience during the remainder of the fiscal year and may be subject to changes based on tax regulations. The Fund or your broker will send you a Form 1099-DIV for the calendar year that will tell you how to report these distributions for federal income tax purposes. About the Fund Duff & Phelps Utility and Infrastructure Fund Inc. is a closed-end investment management company whose investment objective is to seek total return, resulting primarily from (i) a high level of current income, with an emphasis on providing tax-advantaged dividend income and (ii) growth in current income, and secondarily from capital appreciation. The Fund seeks to achieve these objectives by investing primarily in equities of domestic and foreign utilities and infrastructure providers. Under normal market conditions, the Fund will invest at least 80% of its total assets in dividend-paying equity securities of companies in the utility industry and the infrastructure industry. The utility industry is defined to include the following sectors: electric, gas, water, telecommunications, and midstream energy. The infrastructure industry is defined as companies owning or operating essential transportation assets, such as toll roads, bridges, tunnels, airports, seaports, and railroads. For more information, contact shareholder services at (866) 270-7598, by email at duff@ or visit the DPG website, About the Investment Adviser Duff & Phelps Investment Management Co. is a boutique investment manager that specializes in listed real asset strategies for institutional and individual clients. An investment manager of Virtus Investment Partners, Inc. (NYSE: VRTS), the firm began in 1932 as a fundamental research firm and has been managing assets since 1979. The firm seeks to provide specialty investment strategies that enhance client outcomes through active portfolio management and customized solutions, utilizing a process with values that include quality, reliability, and specialization. Investment strategies include U.S. and global real estate securities, global listed infrastructure, energy infrastructure, water, and clean energy. For more information visit View source version on Contacts DPG Fund Services(866) 270-7598duff@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
